SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-096948
Filing Date
2016-04-28
Accepted
2016-04-28 14:48:23
Documents
5
Period of Report
2016-06-10
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v438110_def14a.htm DEF 14A 440872
2 GRAPHIC tlogo.jpg GRAPHIC 12795
3 GRAPHIC tsig.jpg GRAPHIC 8278
4 GRAPHIC tproxy_1.jpg GRAPHIC 339687
5 GRAPHIC tproxy_2.jpg GRAPHIC 255235
  Complete submission text file 0001144204-16-096948.txt   1290680
Mailing Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120
Business Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120 212-946-4826
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 161599252
SIC: 2836 Biological Products, (No Diagnostic Substances)